Detail akcie SPDR S&P BIOTECH ETF online

Business Summary: SPDR S&P Biotech ETF (the Fund) seeks to closely match the returns and characteristics of the S&P Biotechnology Select Industry Index. The S&P Biotechnology Select Industry Index represents the biotechnology sub-industry portion of the S&P Total Markets Index. The S&P TMI tracks all the United States common stocks listed on the New York Stock Exchange, American Stock Exchange, National Association of Securities Dealers Automated Quotation (NASDAQ) National Market and NASDAQ Small Cap exchanges. The Biotech Index is a modified equal weight index. SSgA Funds Management, Inc. is the Fund's investment advisor.
Financial Summary: BRIEF: For the six months ended 31 December 2014, SPDR S&P Biotech (ETF) revenues increased from $3M to $8.3M. Net income increased 31% to $262.3M. Revenues reflect Affiliated Securities increase from $2.9M to $7.8M, Dividend Income on Securities-Unaffiliat increase from $150K to $560K, Dividend Income on Securities-Affiliat increase from $0K to $1K. Net income was partially offset by Advisoryfee increase of 23% to $2.2M (expense).